all you have to do is ask the right questions. Here's what actually happened with PAXLOVID...Note that HCQ+ only changed the pH of a cell to slow down its processing of the virus...it did nothing at all about the critical element, which I've highlighted for you more than once over the last few years (hard to believe, but true).

----------------
AI Overview

Pfizer first began investigating its oral antiviral treatment for COVID-19 on Friday, March 13, 2020. On this date, the company officially tasked a medicinal chemistry team to explore resources needed to develop an oral drug to combat the emerging pandemic.

Key Milestones in Development
March 13, 2020: Drug discovery program initiated internally.
March 17, 2020: Pfizer partnered with BioNTech to develop a preventative vaccine.
March 23, 2021: Phase 1 clinical trials began for the oral antiviral drug.
November 2021: Clinical trial results showed the treatment cut hospitalization and death risks by 89%.
December 2021: The FDA authorized the drug under the brand name Paxlovid

.Scientific Background
Pfizer did not start completely from scratch. Scientists utilized previous research from the 2003 SARS outbreak. They modified an older chemical lead designed to block a critical protease enzyme [3CL] that coronaviruses need to replicate. This historical data allowed Pfizer to accelerate development and bring the pill to clinical trials within a year. More details about the chemical development process are available via the American Chemical Society....
----------------------
i.e. Pfizer was WAY ahead of Drs Fareed and Tyson with their PAXLOVID oral anti-viral product.


Since Dr. Fareed wouldn't take the time and effort to get his study peer-reviewed, don't reward him by spending your money on his book...your choice, though.